# A Single Dose Study of Lu AG09222 in a Headache Model With Healthy Subjects

> **NCT04976309** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 25 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lu AG09222
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04976309
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-15
- **Primary completion:** 2021-09-19
- **Final completion:** 2021-12-10
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04976309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04976309, "A Single Dose Study of Lu AG09222 in a Headache Model With Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04976309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*